Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0540 Transporter Info | ||||
| Gene Name | ATP12A | ||||
| Transporter Name | Potassium-transporting ATPase alpha chain 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Omeprazole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 4594 | ||||
| Docking Score | -5.828 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C17H19N3O3S | ||||
| Molecular Weight | 345.4 | ||||
| Canonical SMILES |
CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
|
||||
| InChI |
InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)
|
||||
| InChIKey | SUBDBMMJDZJVOS-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.2 | Rotatable Bond Count | 5 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Ranitidine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3001055 | ||||
| Docking Score | -4.943 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C13H22N4O3S | ||||
| Molecular Weight | 314.41 | ||||
| Canonical SMILES |
CN/C(=C\\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C
|
||||
| InChI |
InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+
|
||||
| InChIKey | VMXUWOKSQNHOCA-UKTHLTGXSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0.3 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.